Incidence of Adverse Events Related to Therapies with sodium iodine (131I): Contribution to the Pharmacovigilance in Brazil
Radiopharmaceuticals for therapeutic have been increasingly used for the treatment of various pathologies. Beta-emitting radionuclides stand out in this modality due to the physical characteristics of the emitted particle. Iodine-131 (131I) is an example of a beta-emitting radionuclide, applied in t...
Saved in:
Main Authors: | Jaqueline Cardena Fernandes, Elaine Bortoleti de Araújo, Adriana Iozzi Joaquim |
---|---|
Format: | Article |
Language: | English |
Published: |
Brazilian Radiation Protection Society (Sociedade Brasileira de Proteção Radiológica, SBPR)
2024-09-01
|
Series: | Brazilian Journal of Radiation Sciences |
Subjects: | |
Online Access: | https://bjrs.org.br/revista/index.php/REVISTA/article/view/2481 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Evaluation of biokinetics and dosimetry in [131I]-NaI therapies: whole-body images quantification versus lower limb region
by: Bianca Lemos Lima, et al.
Published: (2020-06-01) -
The Impact of Radioiodine (131I) Therapy of Thyroid Disease on Salivary Glands Function and Inflammation: A Comprehensive Review
by: Pietro Bellini, et al.
Published: (2025-06-01) -
Historical aspects and modern concepts in the treatment of patients with differentiated thyroid cancer, refractory to radioactive iodine therapy
by: E. V. Borodavina, et al.
Published: (2022-02-01) -
Brain metastasis from differentiated thyroid carcinoma responding to radioiodine therapy
by: Leo Hashimoto, et al.
Published: (2025-07-01) -
CRITERIA OF WELL-DIFFERENTIATED THYROID CARCINOMA RESISTANCE TO RADIOIODINE THERAPY
by: P. O. Rumyantsev, et al.
Published: (2015-04-01)